1. Oxidative stress and lipid peroxidation products in cancer progression and therapy.
   Giuseppina Barrera, 2012, ISRN Oncol CrossRef
2. Novel Anti-cancer Compounds for Developing Combinatorial Therapies to Target Anoikis-Resistant Tumors
   Lokesh Nagaprashantha et al, 2012, Pharm Res CrossRef
3. RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma
   Sharad S. Singhal et al, 2017, Pharm Res CrossRef
4. RLIP76 Targeted Therapy for Kidney Cancer
   Sharad S. Singhal et al, 2015, Pharm Res CrossRef
5. Chemistry and biochemistry of lipid peroxidation products
   F. Guéraud et al, 2010, Free Radical Research CrossRef
6. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
   Qi Wang et al, 2013, J. Neurooncol. CrossRef
7. Research Progress of RLIP76 in Targeted Therapy of Tumor
   东 刘, 2019, ACM CrossRef
8. The mercapturic acid pathway
   Patrick E. Hanna et al, 2020, Critical Reviews in Toxicology CrossRef
9. Anticancer activity of 2’-hydroxyflavanone towards lung cancer
   Sanjay Awasthi et al, 2018, Oncotarget CrossRef
10. Homeobox protein VentX induces p53-independent apoptosis in cancer cells
    Hong Gao et al, 2016, Oncotarget CrossRef
11. Multicellular Effects of STAT3 in Non-Small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities
    Sagun Parakh et al, 2021, Cancers CrossRef
12. Cardio-protective effects of Terminalia catappa leaves and Terminalia chebula fruit extract in doxorubicin-induced cardiomyopathy in rats
    Manikandan Ramasamy et al, 2022, Biomarkers CrossRef
13. MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines
    Eva-Maria Packeiser et al, 2023, IJMS CrossRef